Plain-English translation of NCT06363981 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study investigates repetitive transcranial magnetic stimulation (rTMS) — a non-invasive treatment that uses magnetic pulses to stimulate the brain — as a way to reduce depression and related symptoms like poor sleep, difficulty concentrating, and loss of interest in activities. The trial compares stimulating two areas of the brain versus one area versus a placebo (fake treatment) to see which approach works best.
About one-third of people with depression don't respond well to antidepressant medications, and depression causes suffering beyond just mood — including cognitive problems, sleep issues, and loss of enjoyment in life. This treatment aims to help people whose medications haven't worked well enough by targeting multiple brain regions at once.
You likely qualify if…
You likely don't qualify if…
You would attend 20 sessions over four weeks (one per weekday). In each session, you'll receive magnetic stimulation to specific areas of your brain — either one area, two areas, or a placebo treatment — lasting about 30–40 minutes. You'll be assigned randomly to one of the three groups. Throughout the study, you'll complete questionnaires about your mood, sleep, and thinking to help researchers track any changes.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Poland